IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
82.12
-0.62 (-0.75%)
Sep 18, 2026, 4:00 PM EDT - Market closed
IRADIMED CORPORATION Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,050 | 1,238 | 697 | 598 | 356 | 570 | |
Market Cap Growth | 16.66% | 77.54% | 16.49% | 68.32% | -37.66% | 103.87% |
Enterprise Value | 991 | 1,181 | 646 | 554 | 302 | 514 |
Last Close Price | 82.12 | 96.65 | 53.79 | 45.98 | 26.22 | 41.97 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 45.88 | 55.05 | 36.24 | 34.81 | 27.71 | 61.16 |
Forward PE | 38.11 | 54.04 | 34.59 | 33.91 | 26.07 | 65.08 |
PS Ratio | 12.16 | 14.77 | 9.52 | 9.13 | 6.67 | 13.64 |
PB Ratio | 10.32 | 13.08 | 8.03 | 8.38 | 4.83 | 7.90 |
P/TBV Ratio | 10.68 | 13.56 | 8.33 | 8.69 | 4.97 | 8.03 |
P/FCF Ratio | 41.81 | 72.02 | 39.56 | 99.33 | 38.56 | 52.93 |
P/OCF Ratio | 38.69 | 49.61 | 27.20 | 44.44 | 35.40 | 50.66 |
PEG Ratio | 3.18 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 11.48 | 14.09 | 8.81 | 8.45 | 5.67 | 12.28 |
EV/EBITDA Ratio | 33.96 | 43.24 | 28.34 | 26.62 | 18.54 | 45.75 |
EV/EBIT Ratio | 35.96 | 45.17 | 29.39 | 27.64 | 19.34 | 52.31 |
EV/FCF Ratio | 39.45 | 68.73 | 36.64 | 91.92 | 32.78 | 47.66 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | - | - | 0 | 0.03 | 0.03 | 0.03 |
Debt / EBITDA Ratio | - | - | 0.00 | 0.10 | 0.13 | 0.21 |
Debt / FCF Ratio | - | - | 0 | 0.34 | 0.24 | 0.23 |
Net Debt / Equity Ratio | -0.58 | -0.54 | -0.60 | -0.67 | -0.76 | -0.83 |
Net Debt / EBITDA Ratio | -2.02 | -1.87 | -2.29 | -2.29 | -3.42 | -5.35 |
Net Debt / FCF Ratio | -2.35 | -2.98 | -2.96 | -7.92 | -6.05 | -5.57 |
Asset Turnover | 0.78 | 0.81 | 0.77 | 0.74 | 0.63 | 0.54 |
Inventory Turnover | 1.78 | 1.77 | 1.46 | 1.69 | 2.49 | 2.37 |
Quick Ratio | 7.89 | 6.37 | 7.38 | 3.80 | 8.33 | 9.91 |
Current Ratio | 9.46 | 7.98 | 8.84 | 4.66 | 9.06 | 11.18 |
Return on Equity (ROE) | 23.52% | 24.78% | 24.31% | 23.70% | 17.59% | 13.96% |
Return on Assets (ROA) | 15.56% | 15.78% | 14.41% | 14.10% | 11.60% | 7.97% |
Return on Invested Capital (ROIC) | 50.37% | 53.11% | 59.72% | 76.15% | 82.40% | 76.68% |
Return on Capital Employed (ROCE) | 26.00% | 26.50% | 24.50% | 26.40% | 20.30% | 12.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.20% | 1.82% | 2.76% | 2.87% | 3.61% | 1.64% |
FCF Yield | 2.39% | 1.39% | 2.53% | 1.01% | 2.59% | 1.89% |
Dividend Yield | 0.97% | 0.73% | 0.87% | 0.33% | - | - |
Payout Ratio | 43.02% | 66.90% | 71.11% | 76.91% | 97.90% | - |
Buyback Yield / Dilution | -0.41% | -0.55% | -0.48% | -0.69% | -0.36% | -1.21% |
Total Shareholder Return | 0.57% | 0.19% | 0.39% | -0.36% | -0.36% | -1.21% |